ANG-3070

N/A

Report date: 2026/03/10 20:00:16
NME

Base Information

Drug NameANG-3070
Drug Alias NameANG-3070
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlatelet-derived growth factor receptor inhibitorsVascular endothelial growth factor receptor antagonists
TargetsPlatelet-derived growth factor receptorVascular endothelial growth factor receptor
Therapy Area/IndicationsProteinuriaGlomerulonephritisIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaGeorgia
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesElicio Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesElicio Therapeutics
Active IndicationsN/A
Inactive IndicationsProteinuriaGlomerulonephritisIdiopathic Pulmonary Fibrosis

Other Information

ATC CodeN/A
Related LinksN/A